Use of proton pump inhibitors and risk of pancreatic cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Use of proton pump inhibitors and risk of pancreatic cancer. / Hicks, Blánaid; Friis, Soren; Pottegard, Anton.
I: Pharmacoepidemiology and Drug Safety, Bind 27, Nr. 8, 2018, s. 926-930.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Hicks, B, Friis, S & Pottegard, A 2018, 'Use of proton pump inhibitors and risk of pancreatic cancer', Pharmacoepidemiology and Drug Safety, bind 27, nr. 8, s. 926-930. https://doi.org/10.1002/pds.4576
APA
Hicks, B., Friis, S., & Pottegard, A. (2018). Use of proton pump inhibitors and risk of pancreatic cancer. Pharmacoepidemiology and Drug Safety, 27(8), 926-930. https://doi.org/10.1002/pds.4576
Vancouver
Hicks B, Friis S, Pottegard A. Use of proton pump inhibitors and risk of pancreatic cancer. Pharmacoepidemiology and Drug Safety. 2018;27(8):926-930. https://doi.org/10.1002/pds.4576
Author
Bibtex
@article{4863c931ade14adabab680c6c99e8427,
title = "Use of proton pump inhibitors and risk of pancreatic cancer",
keywords = "pancreatic cancer, pharmacoepidemiology, proton pump inhibitors",
author = "Bl{\'a}naid Hicks and Soren Friis and Anton Pottegard",
year = "2018",
doi = "10.1002/pds.4576",
language = "English",
volume = "27",
pages = "926--930",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "JohnWiley & Sons Ltd",
number = "8",
}
RIS
TY - JOUR
T1 - Use of proton pump inhibitors and risk of pancreatic cancer
AU - Hicks, Blánaid
AU - Friis, Soren
AU - Pottegard, Anton
PY - 2018
Y1 - 2018
KW - pancreatic cancer
KW - pharmacoepidemiology
KW - proton pump inhibitors
U2 - 10.1002/pds.4576
DO - 10.1002/pds.4576
M3 - Journal article
C2 - 29923251
VL - 27
SP - 926
EP - 930
JO - Pharmacoepidemiology and Drug Safety
JF - Pharmacoepidemiology and Drug Safety
SN - 1053-8569
IS - 8
ER -
ID: 210063084